USPTO issues final rejection of Rampart IC's radiation shield patent claims
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
Upgrades 2025 full-year CDMO sales and margin outlook
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Subscribe To Our Newsletter & Stay Updated